§ 01 Overview
Overview
Khavinson vascular tripeptide (KED) proposed to restore endothelial function and reduce vascular-aging markers.
Khavinson bioregulator literature.
§ 02 Mechanism
Mechanism of action
Vesugen is a short bioregulator hypothesized to modulate endothelial gene expression and support synaptic plasticity. Data is primarily from the Khavinson/Lin'kova group.
- 01Endothelial function support (Russian preclinical)
- 02Synaptic plasticity effects
§ 03 Dosing
Dosing protocol
Standard Protocol
- Dose Range
- 5 – 10 mg per course
- Route
- SubQ
- Frequency
- Daily for 10–20 days
§ 04 Evidence
Evidence & research
Khavinson bioregulator literature.
FDA Status
Not FDA-approved.
§ 06 News
In the news
8 articles from the last 12 months · updates hourly
Blackstone acquires controlling stake in Korea's Futronic for $720 mn to foster humanoid robotics - KED Global
Blackstone acquires controlling stake in Korea's Futronic for $720 mn to foster humanoid robotics KED Global
Korean trading firms expand energy bets as AI lifts power demand - KED Global
Korean trading firms expand energy bets as AI lifts power demand KED Global
Macquarie to acquire Gabia, sending Kosdaq-listed IT firm's shares flying - KED Global
Macquarie to acquire Gabia, sending Kosdaq-listed IT firm's shares flying KED Global
Last German bike helmet maker moves production to China - Nikkei Asia
Last German bike helmet maker moves production to China Nikkei Asia
Conor McGregor Reveals Injury Diagnosis & Return Timeline, 'Knee is F--ked Up,' Says UFC's White - Bleacher Report
Conor McGregor Reveals Injury Diagnosis & Return Timeline, 'Knee is F--ked Up,' Says UFC's White Bleacher Report
El Waili, The Synaptik & BOUMPH! To Perform at KED Beirut August 1st - CairoScene
El Waili, The Synaptik & BOUMPH! To Perform at KED Beirut August 1st CairoScene
Lee calls for safeguards against single-stock leveraged ETFs - KED Global
Lee calls for safeguards against single-stock leveraged ETFs KED Global
SK Hynix’s shares slump in Seoul despite blockbuster Nasdaq ADR debut amid weaker Q2 earnings forecasts - KED Global
SK Hynix’s shares slump in Seoul despite blockbuster Nasdaq ADR debut amid weaker Q2 earnings forecasts KED Global
§ 07 Sourcing
Sourcing & supply
Regulatory status
Authentic supply from international sources
Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product.
International · 2
Cosmic Nootropic
The most credible Russian / Khavinson source for US buyers. Sources authentic bioregulators through 'Peptides Company' (ex-NPCRIZ).
Rupharma
12+ year Russian pharmacy reseller. Reviews.io 4.84/5 (81+). Has a genuine US warehouse for common peptides.
Listings are informational, not endorsement. Verify credentials and flags against FDA and PCAB databases before purchasing. Full directory & how to verify →
§ 09 Safety
Safety & side effects
Side effects
- 01Limited data
Contraindications
None specified.
§ 10 Questions
Vesugen FAQ
- What is Vesugen?
- Khavinson vascular tripeptide (KED) proposed to restore endothelial function and reduce vascular-aging markers. Vesugen is a short bioregulator hypothesized to modulate endothelial gene expression and support synaptic plasticity. Data is primarily from the Khavinson/Lin'kova group.
- What is Vesugen used for?
- Reported uses include endothelial function support (russian preclinical) and synaptic plasticity effects. Evidence strength is rated Preclinical — see the evidence section for detail.
- How is Vesugen dosed?
- Commonly referenced dosing is 5 – 10 mg per course, typically daily for 10–20 days, administered SubQ. This is educational reference only; consult a licensed clinician before use.
- What are the side effects of Vesugen?
- Commonly reported side effects include limited data. This list is not exhaustive.
- Is Vesugen legal?
- Authentic product originates from specific international manufacturers, most commonly Russian pharmaceutical facilities for Khavinson bioregulators. RUO vendors selling the same name are typically Chinese-synthesized research vials, not the original product. FDA status: Not FDA-approved..
§ 11 References
Selected references
- 01
Lin'kova Adv Gerontol 2016
Russian literature